- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 512
Marqeta makes off with $150m
An undisclosed investor provided the funding at a $4.3bn valuation, Marqeta having previously raised nearly $370m from backers including Commerzbank, Visa and CreditEase.
May 29, 2020Cisco sets aside $1bn for ThousandEyes acquisition
Cisco intends to purchase the network analytics software producer, which had raised more than $110m from investors including GV and Salesforce Ventures, for a reported $1bn.
May 29, 2020Pie Insurance picks out $127m
Existing investor Sirius was among the investors as the worker's compensation provider received a total of $127m, with $100m allocated to the launch of an affiliate called Pie Carrier.
May 29, 2020Vision Fund prepares for job cuts
Vision Fund is reportedly set to reduce the size of a 500-strong team by about 10% in the wake of some $18bn in losses over the past year.
May 29, 2020Aircall rings up $65m
The call management platform developer has completed a series C round led by DTCP that also featured Swisscom Ventures.
May 29, 2020DefinedCrowd attracts series B funding
EDP Ventures and Semapa Next took part in a $50.5m series B round for the AI verification data provider, which counts Amazon, Sony and Mastercard as earlier investors.
May 29, 2020Ascus Biosciences gets fed $46m
Cavallo Ventures contributed to a series B round for the microbial animal feed producer that will fund product development and recruitment.
May 29, 2020Daily deal net: May 28, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
May 28, 2020AbCellera accelerates with $105m
University of Minnesota has invested in UBC spinout AbCellera's series B round that also included Eli Lilly.
May 28, 2020Pliant places IPO terms
Existing investor Novartis has committed to a $10m private placement alongside the IPO, in which the fibrosis therapy developer, based on UCSF research, is set to raise up to $96m.
May 28, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


